The efficacy and safety of weekly 35-mg risedronate dosing regimen for Chinese postmenopausal women with osteoporosis or osteopenia: 1-year data.
Gu JM, Wang L, Lin H, Chen DC, Tang H, Jin XL, Xia WB, Hu YQ, Fu WZ, He JW, Zhang H, Wang C, Yue H, Hu WW, Liu YJ, Zhang ZL.
Gu JM, et al. Among authors: wang l, wang c.
Acta Pharmacol Sin. 2015 Jul;36(7):841-6. doi: 10.1038/aps.2015.30. Epub 2015 Jun 8.
Acta Pharmacol Sin. 2015.
PMID: 26051110
Free PMC article.
Clinical Trial.